Obesity and Serial NT‐proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE‐IT Trial

BACKGROUND: Obese patients have lower NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) levels. The prognostic implications of achieving NT‐proBNP levels ≤1000 pg/mL in obese patients with heart failure (HF) receiving biomarker‐guided therapy are not completely known. We evaluated the prognostic...

Full description

Saved in:
Bibliographic Details
Published in:J Am Heart Assoc
Main Authors: Parcha, Vibhu, Patel, Nirav, Kalra, Rajat, Suri, Sarabjeet S., Arora, Garima, Wang, Thomas J., Arora, Pankaj
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2021
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8174357/
https://ncbi.nlm.nih.gov/pubmed/33754794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.018689
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items